- Home
- ABUS vs XYF Comparison
ABUS vs XYF Comparison
Compare ABUS & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- XYF
- Stock Information
- Founded
- ABUS 2005
- XYF 2014
- Country
- ABUS United States
- XYF China
- Employees
- ABUS N/A
- XYF N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- XYF Finance: Consumer Services
- Sector
- ABUS Health Care
- XYF Finance
- Exchange
- ABUS Nasdaq
- XYF Nasdaq
- Market Cap
- ABUS 611.0M
- XYF 708.7M
- IPO Year
- ABUS N/A
- XYF 2018
- Fundamental
- Price
- ABUS $3.37
- XYF $13.44
- Analyst Decision
- ABUS Strong Buy
- XYF
- Analyst Count
- ABUS 3
- XYF 0
- Target Price
- ABUS $5.67
- XYF N/A
- AVG Volume (30 Days)
- ABUS 636.5K
- XYF 536.3K
- Earning Date
- ABUS 08-06-2025
- XYF 08-18-2025
- Dividend Yield
- ABUS N/A
- XYF 3.74%
- EPS Growth
- ABUS N/A
- XYF 32.83
- EPS
- ABUS N/A
- XYF 4.76
- Revenue
- ABUS $15,416,000.00
- XYF $909,710,294.00
- Revenue This Year
- ABUS $3.35
- XYF N/A
- Revenue Next Year
- ABUS N/A
- XYF N/A
- P/E Ratio
- ABUS N/A
- XYF $2.94
- Revenue Growth
- ABUS 53.23
- XYF 31.55
- 52 Week Low
- ABUS $2.71
- XYF $4.22
- 52 Week High
- ABUS $4.73
- XYF $20.36
- Technical
- Relative Strength Index (RSI)
- ABUS 54.05
- XYF 34.03
- Support Level
- ABUS $3.33
- XYF $13.31
- Resistance Level
- ABUS $3.45
- XYF $14.64
- Average True Range (ATR)
- ABUS 0.12
- XYF 0.77
- MACD
- ABUS 0.01
- XYF 0.02
- Stochastic Oscillator
- ABUS 36.21
- XYF 15.58
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.